Jackson Frolic : Maybe next week? BioAge had a multi day rise after weaker news. The Gilead purchase was significant validation of the technology IMO
Jackson Frolic : Maybe next week? BioAge had a multi day rise after weaker news. The Gilead purchase was significant validation of the technology IMO